Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIR-16009802Phase 3Recruiting
Phase 3, randomised trial of tegafur and paclitaxel in gastric adenocarcinoma (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Overall survival. Started Jan 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIR-16009802.